Alveolar Cleft Hard- and Soft Tissue Reconstruction With an Autogenous Tooth Derived Particulate Graft

Sponsor
Semmelweis University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05971914
Collaborator
(none)
8
1
1
21.6
0.4

Study Details

Study Description

Brief Summary

The present study aims at clinical and radiographic evaluation of the safety and efficacy of Bonmaker ATB powder combined with a novel split thickness papilla curtain flap in the treatment of alveolar cleft defects.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Autogenous tooth derived particulate graft and a novel split thickness papilla curtain flap
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Eight patients aged 8-12 years exhibiting uni- or bilateral alveolar cleft defects and oronasal fistulas underwent supra-, subgingival scaling and received individual oral hygiene instructions prior to surgery at the Department of Periodontology, Semmelweis University, Budapest, Hungary. Surgeries will be performed at the I. Department of Paediatrics, Semmelweis University, Budapest, Hungary between January 2021 and November 2021. The study was approved by the Semmelweis University Regional and Institutional Committee of Science and Research Ethics (Approval Number SE TUKEB x/2020). Patients is treated in accordance with the World Medical Association Declaration of Helsinki (version 2008). Surgical interventions are undertaken with the understanding and written consent of each subject's caregiverEight patients aged 8-12 years exhibiting uni- or bilateral alveolar cleft defects and oronasal fistulas underwent supra-, subgingival scaling and received individual oral hygiene instructions prior to surgery at the Department of Periodontology, Semmelweis University, Budapest, Hungary. Surgeries will be performed at the I. Department of Paediatrics, Semmelweis University, Budapest, Hungary between January 2021 and November 2021. The study was approved by the Semmelweis University Regional and Institutional Committee of Science and Research Ethics (Approval Number SE TUKEB x/2020). Patients is treated in accordance with the World Medical Association Declaration of Helsinki (version 2008). Surgical interventions are undertaken with the understanding and written consent of each subject's caregiver
Masking:
None (Open Label)
Masking Description:
no masking
Primary Purpose:
Treatment
Official Title:
Alveolar Cleft Hard- and Soft Tissue Reconstruction With an Autogenous Tooth Derived Particulate Graft
Actual Study Start Date :
Oct 12, 2021
Anticipated Primary Completion Date :
Jul 30, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Autogenous tooth derived particulate graft and a novel split thickness papilla curtain flap

Extracted deciduous teeth were prepared immediately after removal according to the manufacturer's instructions with the Bonmaker® device. Ready to use autogenous tooth bone graft (ATB) was mixed with fibrin glue in 3D planned and printed plastic cuvettes to obtain a sticky graft closely matching the shape and extent of the bony defect. The preshaped sticky ATB graft was inserted and compacted in the cleft defect. Subsequently, the tension-free split thickness flap was repositioned by shifting all buccal surgical papillae mesially to the adjacent or the second adjacent interproximal space, depending on the horizontal extent of the cleft.

Procedure: Autogenous tooth derived particulate graft and a novel split thickness papilla curtain flap
Extracted deciduous teeth were prepared immediately after removal according to the manufacturer's instructions with the Bonmaker® device. Ready to use autogenous tooth bone graft (ATB) was mixed with fibrin glue in 3D planned and printed plastic cuvettes to obtain a sticky graft closely matching the shape and extent of the bony defect. The preshaped sticky ATB graft was inserted and compacted in the cleft defect. Subsequently, the tension-free split thickness flap was repositioned by shifting all buccal surgical papillae mesially to the adjacent or the second adjacent interproximal space, depending on the horizontal extent of the cleft.

Outcome Measures

Primary Outcome Measures

  1. Radiological volumetric measurements [6 months]

    Volumetric measurements will be conducted after the healing period. On prealigned pre- and postoperative CBCT cross-sections, linear measurements and volumetric measurements will be taken parallel to a reference base to determine the width of the surgical area.

Secondary Outcome Measures

  1. soft tissue healing [during the 6 months postoperatively]

    Healing of soft tissues was recorded via photo documentation.

  2. complications [1, 14, 30 days and 3 and 6 months after surgeries.]

    Every complication will be reported

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • children with alveolar cleft

  • patient presented at least three deciduous teeth scheduled for extraction.

Exclusion Criteria:
  • major relevant clinical diseases,

  • systemic use of steroids,

  • current or previous intravenous bisphosphonate treatment,

  • acute infection at the operation site.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Semmelweis University Department of Periodontology Budapest Hungary 1088

Sponsors and Collaborators

  • Semmelweis University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Nagy Krisztián, Associate Professor, Semmelweis University
ClinicalTrials.gov Identifier:
NCT05971914
Other Study ID Numbers:
  • Cleftgraft-Semmelweis
First Posted:
Aug 2, 2023
Last Update Posted:
Aug 2, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Nagy Krisztián, Associate Professor, Semmelweis University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 2, 2023